Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742182015 | Physostigmine only product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3742183013 | Product containing only physostigmine in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Physostigmine only product in ocular dose form | Is a | Physostigmine-containing product in ocular dose form | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Has active ingredient | Physostigmine | true | Inferred relationship | Some | 1 | |
| Physostigmine only product in ocular dose form | Is a | Physostigmine only product | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Physostigmine sulfate 10 mg/mL eye solution | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some | |
| Physostigmine salicylate 2.5 mg/mL eye solution | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some | |
| Physostigmine salicylate 5 mg/mL eye solution | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR